ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Anxiety in breast cancer research (1982-2024): a bibliometric analysis.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in male breast cancer in Spain, 1999-2023: a nationwide analysis of incidence and mortality.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundBreast cancer remains a major global malignancy, with anxiety severely impacting patients' quality of life and treatment outcomes. Understanding evolving research trends is critical for developing effective interventions. This study examines 40-year trends, collaborations, and knowledge structures in breast cancer anxiety research. The goal is to inform future directions for psychosocial oncology research and policymaking.
methodsArticles and reviews related to breast cancer and anxiety were retrieved from the Web of Science Core Collection (WoSCC). Medical Subject Headings (MeSH) and corresponding entry terms were employed to optimize the search strategy. CiteSpace (Version 6.4.R1), VOSviewer (Version 1.6.19), and the Bibliometrix R package were used to construct knowledge maps, visualize collaboration networks, monitor journal and author metrics over time, and calculate key indicators such as publication and citation counts. Regression analysis was applied to predict future development trends.
resultsAnalysis of 4376 publications revealed a surge in research post-2006, peaking at 316 publications in 2021. The United States led in publications (1333 articles) and citations (56,008), followed by China, England, and Canada. The University of Sydney ranked first institutionally, and Christine Miaskowski was the most influential author. Psycho-Oncology and Supportive Care in Cancer were the leading journals. Co-citation and reference clustering identified key themes, including the psychological impact of COVID-19, psychological interventions, and long-term survivorship. Keyword analysis revealed a consistent focus on terms such as "cancer survivor" and "mental health," with recent trends in "telehealth," "digital interventions," and "mindfulness."
conclusionOur analysis confirms a paradigm shift toward psychosocial and digital health interventions in breast cancer anxiety research. The findings advocate for integrated, patient-centered care models and highlight untapped potential in low-resource regions. Future research should prioritize scalable digital tools to address global disparities.
Indexed as
Identifiers
41241668What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.